Guang-Hai Dai (Guanghai Dai)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Metastatic Colorectal Cancer

Circulating Tumor

Top Venues

Disease markers

Journal of immunology research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Miaomiao Gou, Tongtong Qu, Zhikuan Wang, Huan Yan, Yanhai Si, Yong Zhang, Guang-Hai Dai
Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer. Journal of immunology research 2021 (2021)
Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, Qi Li, Nong Xu, Xi-Chun Hu, Wangjun Liao, Yi Jiang, Xiao-Yan Lin, Qing-Yuan Zhang, Xiang-Lin Yuan, Hai-Xin Huang, Ye Chen, Guang-Hai Dai, Jian-Hua Shi, Lin Shen, Shu-Jun Yang, Yong-Qian Shu, Yun-Peng Liu, Weifeng Wang, Hai Wu, Hui Feng, Sheng Yao, Rui-Hua Xu
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)
Jun Jia, Pengfei Zhang, Miaomiao Gou, Fan Yang, Niansong Qian, Guang-Hai Dai
The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer. Disease markers 2019 (2019)